For help on how to get the results you want, see our search tips.
2 results
Categories
Human Remove Human filter
Medicine
Referrals Remove Referrals filter
Referral PRAC recommendation
Risk minimisation measures Remove Risk minimisation measures filter
Revocation Remove Revocation filter
No further action Remove No further action filter
Referral type
Article 20 procedures Remove Article 20 procedures filter
Article 107i procedures Remove Article 107i procedures filter
Referral status
European Commission final decision Remove European Commission final decision filter
CMDh final position Remove CMDh final position filter
Referral safety status
Yes Remove Yes filter
-
List item
Referral: Xeljanz
tofacitinib, associated names: Xeljanz, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 31/01/2020, Last updated: 06/03/2020 -
List item
Referral: Lemtrada
alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020